Grifols is a global healthcare company dedicated to improving the health and well-being of people around the world.

Established in Barcelona, Spain in 1940, we are an industry leader in the production of plasma-derived medicines, with 20,000 employees across 30 countries.

As our business continues to grow, we remain committed to a long-term, sustainable and responsible vision.

Mission

We improve the health and well-being of patients around the world.

Read more

Family heritage

We trace our roots back to 1940 when Dr. Josep Antoni Grífols i Roig founded Laboratorios Grifols in Barcelona, Spain.

Read more
Grifols Grifols

COMMITMENT

Commitment to patients

The patients we serve around the world are able to lead better lives thanks to plasma-derived medicines and donors. Patients inspire the work we do every day.

Latest news

See more
08 jan, 2019 Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions
Read more

19 dec, 2018 Grifols partners with the Republic of Liberia to explore an innovative approach to combat Ebola virus disease
Read more

15 nov, 2018 Grifols introduces AlfaCare in Spain, the first support program for patients with Alpha-1 Antitrypsin Deficiency (AATD)
Read more

Company

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies.

Read more

Commitment

We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate.

Read more

Innovation

Since the foundation of Grifols, our on-going innovation has helped shape industry standards in the plasma medicines sector.

Read more

Team

The efforts of every member of the Grifols team enable us to achieve our mission of improving people's health and well-being.

Read more